Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative movement disorder that presents with prominent cognitive and psychiatric dysfunction. Brain-derived neurotrophic factor (BDNF) plays an important role in the pathophysiology of HD, as well as other neurodegenerative and psychiatric...
Main Authors: | Ashley Gutierrez, Jody Corey-Bloom, Elizabeth A. Thomas, Paula Desplats |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2019.00335/full |
Similar Items
-
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease
by: Paula A. Desplats, et al.
Published: (2008-09-01) -
ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation
by: Tina Zimmermann, et al.
Published: (2016-10-01) -
Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington’s disease
by: Shotaro Kishikawa, et al.
Published: (2006-11-01) -
The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease
by: Noel J. Buckley, et al.
Published: (2010-07-01) -
Glycolipid and ganglioside metabolism imbalances in Huntington's disease
by: Paula A. Desplats, et al.
Published: (2007-09-01)